Global HMO Infant Formula Market Research Report 2024

Publication ID:

PB508248289

Publication Date:

August 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Retailing [2]

Consumer & Retail [3]

Description:

The global HMO Infant Formula market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for HMO Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HMO Infant Formula is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of HMO Infant Formula include Abbott, 狈别蝉迟濒茅, Wyeth Nutrition, Hoeslandt, Friesland Foods, Hyproca, Aptamil, Biostime and Mengniu Dairy, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HMO Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Infant Formula.
Report Scope
The HMO Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HMO Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMO Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
狈别蝉迟濒茅
Wyeth Nutrition
Hoeslandt
Friesland Foods
Hyproca
Aptamil
Biostime
Mengniu Dairy
Yili Group
Feihe
Junlebao Dairy Group
Segment by Type
2'-Fucosyllactose (2'-FL)
3-Fucosyllactose (3-FL)
Lactose-N-neotetraose (LNnT)
3'-Sialyllactose (3'-SL)
6'-Sialyllactose (6'-SL)
Segment by Application
Online Channel
Specialty Store
Supermarket
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HMO Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 HMO Infant Formula Market Overview
1.1 Product Overview and Scope of HMO Infant Formula
1.2 HMO Infant Formula Segment by Type
1.2.1 Global HMO Infant Formula Market Value Comparison by Type (2024-2030)
1.2.2 2'-Fucosyllactose (2'-FL)
1.2.3 3-Fucosyllactose (3-FL)
1.2.4 Lactose-N-neotetraose (LNnT)
1.2.5 3'-Sialyllactose (3'-SL)
1.2.6 6'-Sialyllactose (6'-SL)
1.3 HMO Infant Formula Segment by Application
1.3.1 Global HMO Infant Formula Market Value by Application: (2024-2030)
1.3.2 Online Channel
1.3.3 Specialty Store
1.3.4 Supermarket
1.3.5 Other
1.4 Global HMO Infant Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Infant Formula Revenue 2019-2030
1.4.2 Global HMO Infant Formula Sales 2019-2030
1.4.3 Global HMO Infant Formula Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HMO Infant Formula Market Competition by Manufacturers
2.1 Global HMO Infant Formula Sales Market Share by Manufacturers (2019-2024)
2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HMO Infant Formula Average Price by Manufacturers (2019-2024)
2.4 Global HMO Infant Formula Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMO Infant Formula, Product Type & Application
2.7 HMO Infant Formula Market Competitive Situation and Trends
2.7.1 HMO Infant Formula Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest HMO Infant Formula Players Market Share by Revenue
2.7.3 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HMO Infant Formula Retrospective Market Scenario by Region
3.1 Global HMO Infant Formula Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HMO Infant Formula Global HMO Infant Formula Sales by Region: 2019-2030
3.2.1 Global HMO Infant Formula Sales by Region: 2019-2024
3.2.2 Global HMO Infant Formula Sales by Region: 2025-2030
3.3 Global HMO Infant Formula Global HMO Infant Formula Revenue by Region: 2019-2030
3.3.1 Global HMO Infant Formula Revenue by Region: 2019-2024
3.3.2 Global HMO Infant Formula Revenue by Region: 2025-2030
3.4 North America HMO Infant Formula Market Facts & Figures by Country
3.4.1 North America HMO Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HMO Infant Formula Sales by Country (2019-2030)
3.4.3 North America HMO Infant Formula Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Infant Formula Market Facts & Figures by Country
3.5.1 Europe HMO Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HMO Infant Formula Sales by Country (2019-2030)
3.5.3 Europe HMO Infant Formula Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Infant Formula Market Facts & Figures by Country
3.6.1 Asia Pacific HMO Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HMO Infant Formula Sales by Country (2019-2030)
3.6.3 Asia Pacific HMO Infant Formula Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Infant Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HMO Infant Formula Sales by Country (2019-2030)
3.7.3 Latin America HMO Infant Formula Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Infant Formula Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HMO Infant Formula Sales by Country (2019-2030)
3.8.3 Middle East and Africa HMO Infant Formula Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Infant Formula Sales by Type (2019-2030)
4.1.1 Global HMO Infant Formula Sales by Type (2019-2024)
4.1.2 Global HMO Infant Formula Sales by Type (2025-2030)
4.1.3 Global HMO Infant Formula Sales Market Share by Type (2019-2030)
4.2 Global HMO Infant Formula Revenue by Type (2019-2030)
4.2.1 Global HMO Infant Formula Revenue by Type (2019-2024)
4.2.2 Global HMO Infant Formula Revenue by Type (2025-2030)
4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2019-2030)
4.3 Global HMO Infant Formula Price by Type (2019-2030)
5 Segment by Application
5.1 Global HMO Infant Formula Sales by Application (2019-2030)
5.1.1 Global HMO Infant Formula Sales by Application (2019-2024)
5.1.2 Global HMO Infant Formula Sales by Application (2025-2030)
5.1.3 Global HMO Infant Formula Sales Market Share by Application (2019-2030)
5.2 Global HMO Infant Formula Revenue by Application (2019-2030)
5.2.1 Global HMO Infant Formula Revenue by Application (2019-2024)
5.2.2 Global HMO Infant Formula Revenue by Application (2025-2030)
5.2.3 Global HMO Infant Formula Revenue Market Share by Application (2019-2030)
5.3 Global HMO Infant Formula Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott HMO Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 狈别蝉迟濒茅
6.2.1 狈别蝉迟濒茅 Corporation Information
6.2.2 狈别蝉迟濒茅 Description and Business Overview
6.2.3 狈别蝉迟濒茅 HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.2.4 狈别蝉迟濒茅 HMO Infant Formula Product Portfolio
6.2.5 狈别蝉迟濒茅 Recent Developments/Updates
6.3 Wyeth Nutrition
6.3.1 Wyeth Nutrition Corporation Information
6.3.2 Wyeth Nutrition Description and Business Overview
6.3.3 Wyeth Nutrition HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Wyeth Nutrition HMO Infant Formula Product Portfolio
6.3.5 Wyeth Nutrition Recent Developments/Updates
6.4 Hoeslandt
6.4.1 Hoeslandt Corporation Information
6.4.2 Hoeslandt Description and Business Overview
6.4.3 Hoeslandt HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hoeslandt HMO Infant Formula Product Portfolio
6.4.5 Hoeslandt Recent Developments/Updates
6.5 Friesland Foods
6.5.1 Friesland Foods Corporation Information
6.5.2 Friesland Foods Description and Business Overview
6.5.3 Friesland Foods HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Friesland Foods HMO Infant Formula Product Portfolio
6.5.5 Friesland Foods Recent Developments/Updates
6.6 Hyproca
6.6.1 Hyproca Corporation Information
6.6.2 Hyproca Description and Business Overview
6.6.3 Hyproca HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hyproca HMO Infant Formula Product Portfolio
6.6.5 Hyproca Recent Developments/Updates
6.7 Aptamil
6.6.1 Aptamil Corporation Information
6.6.2 Aptamil Description and Business Overview
6.6.3 Aptamil HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aptamil HMO Infant Formula Product Portfolio
6.7.5 Aptamil Recent Developments/Updates
6.8 Biostime
6.8.1 Biostime Corporation Information
6.8.2 Biostime Description and Business Overview
6.8.3 Biostime HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biostime HMO Infant Formula Product Portfolio
6.8.5 Biostime Recent Developments/Updates
6.9 Mengniu Dairy
6.9.1 Mengniu Dairy Corporation Information
6.9.2 Mengniu Dairy Description and Business Overview
6.9.3 Mengniu Dairy HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mengniu Dairy HMO Infant Formula Product Portfolio
6.9.5 Mengniu Dairy Recent Developments/Updates
6.10 Yili Group
6.10.1 Yili Group Corporation Information
6.10.2 Yili Group Description and Business Overview
6.10.3 Yili Group HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yili Group HMO Infant Formula Product Portfolio
6.10.5 Yili Group Recent Developments/Updates
6.11 Feihe
6.11.1 Feihe Corporation Information
6.11.2 Feihe HMO Infant Formula Description and Business Overview
6.11.3 Feihe HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Feihe HMO Infant Formula Product Portfolio
6.11.5 Feihe Recent Developments/Updates
6.12 Junlebao Dairy Group
6.12.1 Junlebao Dairy Group Corporation Information
6.12.2 Junlebao Dairy Group HMO Infant Formula Description and Business Overview
6.12.3 Junlebao Dairy Group HMO Infant Formula Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Junlebao Dairy Group HMO Infant Formula Product Portfolio
6.12.5 Junlebao Dairy Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Infant Formula Industry Chain Analysis
7.2 HMO Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Infant Formula Production Mode & Process
7.4 HMO Infant Formula Sales and Marketing
7.4.1 HMO Infant Formula Sales Channels
7.4.2 HMO Infant Formula Distributors
7.5 HMO Infant Formula Customers
8 HMO Infant Formula Market Dynamics
8.1 HMO Infant Formula Industry Trends
8.2 HMO Infant Formula Market Drivers
8.3 HMO Infant Formula Market Challenges
8.4 HMO Infant Formula Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott
狈别蝉迟濒茅
Wyeth Nutrition
Hoeslandt
Friesland Foods
Hyproca
Aptamil
Biostime
Mengniu Dairy
Yili Group
Feihe
Junlebao Dairy Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂